EP Patent

EP4028126B1 — Treatment of a neurological disease with complement inhibitors

Assigned to UCB Holdings Inc · Expires 2025-02-26 · 1y expired

What this patent protects

Patent listed against zilucoplan-sodium.

Drugs covered by this patent

zilucoplan-sodium (ZILUCOPLAN SODIUM)

Patent Metadata

Patent number: EP4028126B1
Jurisdiction: EP
Classification: —
Expires: 2025-02-26
Drug substance claim: No
Drug product claim: No
Assignee: UCB Holdings Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.